Norgestrel

A synthetic progestogen, used in combination with estrogen as an oral contraceptive.

Brands
PROGYLUTON ESTRANOR NORESTRA
Adult Dose
Neonatal
Paedriatic
Characteristics
belongs to Progesleogen. . The Molecular Weight of Norgestrel is 312.45.
Contraindications
Norgestrel is contraindicated in conditions like Genital bleeding,Hepatic carcinoma,Endometrial cancer,Thrombo-embolic complications,Hypersensitivity to any component of product.
Effects
The signs and symptoms that are produced after the acute overdosage of Norgestrel include Dizziness, Nausea & vomiting, Sleepiness, Withdrawal bleeding in females.The symptomatic adverse reactions produced by Norgestrel are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Fatigue, Redness, Depression, Hair loss, Acne, Faintness.
Indications
Norgestrel is primarily indicated in conditions like Contraception.
Interactions
No data regarding the interactions of Norgestrel was found.
Interfrence
Liver Function Test (LFT)
Risks
Drug should not be given to Pregnant Mothers, Cardiac / Hypertensive Patients, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Before you take this medication, tell your doctor your medical history (including family medical history), especially if you have: asthma, high blood pressure, kidney or liver diseases, heart disease, history of jaundice (yellowing of skin or eyes) or high blood pressure during pregnancy, excessive weight gain or fluid retention during your menstrual cycle, strokes, blood clots, heart attacks, seizures, migraine headaches, breast cancer, high blood level of cholesterol or lipids (fats), depression. Oral contraceptives may cause some degree of fluid retention. They should be prescribed with caution, and only with careful monitoring, in patients with conditions which might be aggravated by fluid retention.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.